TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study.

Sam J Lubner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.